Cite
HARVARD Citation
Xu, M. et al. (2016). Expression of CD30 as a biomarker to predict response to brentuximab vedotin. Histopathology. 69 (1), pp. 155-158. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, M. et al. (2016). Expression of CD30 as a biomarker to predict response to brentuximab vedotin. Histopathology. 69 (1), pp. 155-158. [Online].